Main
Synthetic Genomics and ExxonMobil are collaborating to research and commercialize biofuels from photosynthetic algae. Dr. Emil Jacobs, vice president of research and development, sees the algae pathway to biofuel as a promising experiment for ExxonMobil. The research partnership has established stages of investment with milestones that could see ExxonMobil invest over $600 million.
View the Original article